EU Clears $63B AbbVie-Allergan Deal With Drug Sale
European Commission antitrust authorities signed off Friday on AbbVie's proposed $63 billion purchase of Allergan on the condition that the drugmakers divest an inflammatory bowel disease treatment currently under development at...To view the full article, register now.
Already a subscriber? Click here to view full article